ctrl K

Watchlist Price Alert

Rein Therapeutics Inc. (RNTX)

NASDAQ: RNTX · Real-Time Price · USD

1.42

-0.05 (-3.40%)

At close: Jun 30, 2025, 3:59 PM

1.40

-1.41%

After-hours: Jun 30, 2025, 04:04 PM EDT

Rein Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-65.11M	-16.28K	-27.65K	-26.61K	-20.5K
Interest Income	400K	n/a	n/a	n/a	n/a
Pretax Income	-64.31M	-15.73K	-27.33K	-26.16K	-21.16K
Net Income	-62.88M	-15.73K	-27.33K	-26.16K	-21.16K
Selling & General & Admin	13.86K	11.36K	9.68K	9.6K	9.33K
Research & Development	14.25K	3.99K	17.97K	17.01K	11.17K
Other Expenses	n/a	928.00	n/a	n/a	n/a
Operating Expenses	65.11K	16.28K	27.65K	26.61K	20.5K
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-13.85M	n/a	n/a	n/a	n/a
Cost & Expenses	65.11K	16.28K	27.65K	26.61K	20.5K
Income Tax Expense	-1.54M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	17.94K	4.6K	4.54K	4.44K	1.74K
Shares Outstanding (Diluted)	17.94K	4.6K	4.54K	4.44K	1.74K
EPS (Basic)	-3.51	-3.42	-6.02	-5.89	-12.14
EPS (Diluted)	-3.51	-3.42	-6.02	-5.89	-12.14
EBITDA	-28.05M	-15.23K	-27.48K	-26.48K	-20.33K
EBIT	-28.11M	-15.35K	-27.65K	-26.61K	-20.5K
Depreciation & Amortization	63K	119.00	169.00	121.00	163.00